Annual Retained Earnings
-$48.48 M
-$5.09 M-11.72%
December 31, 2023
Summary
- As of February 26, 2025, LIXT annual retained earnings is -$48.48 million, with the most recent change of -$5.09 million (-11.72%) on December 31, 2023.
- During the last 3 years, LIXT annual retained earnings has fallen by -$18.13 million (-59.72%).
- LIXT annual retained earnings is now -301028.57% below its all-time high of -$16.10 thousand, reached on December 31, 2005.
Performance
LIXT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$51.45 M
-$986.00 K-1.95%
September 30, 2024
Summary
- As of February 26, 2025, LIXT quarterly retained earnings is -$51.45 million, with the most recent change of -$986.00 thousand (-1.95%) on September 30, 2024.
- Over the past year, LIXT quarterly retained earnings has stayed the same.
- LIXT quarterly retained earnings is now -147321.20% below its all-time high of -$34.90 thousand, reached on March 31, 2006.
Performance
LIXT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
LIXT Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.7% | 0.0% |
| 3 y3 years | -59.7% | -10.8% |
| 5 y5 years | -96.7% | -10.8% |
LIXT Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.7% | at low | -38.8% | at low |
| 5 y | 5-year | -79.0% | at low | -89.9% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Lixte Biotechnology Holdings Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$51.45 M(+2.0%) |
| Jun 2024 | - | -$50.46 M(+2.0%) |
| Mar 2024 | - | -$49.45 M(+2.0%) |
| Dec 2023 | -$48.48 M(+11.7%) | -$48.48 M(+2.2%) |
| Sep 2023 | - | -$47.45 M(+2.2%) |
| Jun 2023 | - | -$46.43 M(+3.7%) |
| Mar 2023 | - | -$44.76 M(+3.2%) |
| Dec 2022 | -$43.39 M(+17.0%) | -$43.39 M(+3.9%) |
| Sep 2022 | - | -$41.76 M(+3.7%) |
| Jun 2022 | - | -$40.29 M(+4.0%) |
| Mar 2022 | - | -$38.74 M(+4.5%) |
| Dec 2021 | -$37.08 M(+22.2%) | -$37.08 M(+5.8%) |
| Sep 2021 | - | -$35.05 M(+3.7%) |
| Jun 2021 | - | -$33.81 M(+5.4%) |
| Mar 2021 | - | -$32.08 M(+5.7%) |
| Dec 2020 | -$30.35 M(+12.1%) | -$30.35 M(+3.1%) |
| Sep 2020 | - | -$29.45 M(+5.8%) |
| Jun 2020 | - | -$27.85 M(+1.4%) |
| Mar 2020 | - | -$27.47 M(+1.4%) |
| Dec 2019 | -$27.09 M(+9.9%) | -$27.09 M(+1.2%) |
| Sep 2019 | - | -$26.77 M(+4.2%) |
| Jun 2019 | - | -$25.69 M(+2.4%) |
| Mar 2019 | - | -$25.08 M(+1.7%) |
| Dec 2018 | -$24.65 M(+9.5%) | -$24.65 M(+1.4%) |
| Sep 2018 | - | -$24.30 M(+4.4%) |
| Jun 2018 | - | -$23.27 M(+1.6%) |
| Mar 2018 | - | -$22.89 M(+1.7%) |
| Dec 2017 | -$22.52 M(+8.7%) | -$22.52 M(+2.0%) |
| Sep 2017 | - | -$22.08 M(+2.1%) |
| Jun 2017 | - | -$21.62 M(+1.4%) |
| Mar 2017 | - | -$21.33 M(+3.0%) |
| Dec 2016 | -$20.71 M(+11.5%) | -$20.71 M(+2.6%) |
| Sep 2016 | - | -$20.19 M(+3.3%) |
| Jun 2016 | - | -$19.54 M(+2.9%) |
| Mar 2016 | - | -$18.99 M(+2.2%) |
| Dec 2015 | -$18.57 M | -$18.57 M(+3.4%) |
| Sep 2015 | - | -$17.96 M(+4.5%) |
| Jun 2015 | - | -$17.18 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | -$16.68 M(+6.1%) |
| Dec 2014 | -$15.72 M(+21.4%) | -$15.72 M(+3.9%) |
| Sep 2014 | - | -$15.12 M(+3.4%) |
| Jun 2014 | - | -$14.62 M(+5.3%) |
| Mar 2014 | - | -$13.88 M(+7.2%) |
| Dec 2013 | -$12.95 M(+11.9%) | -$12.95 M(+2.9%) |
| Sep 2013 | - | -$12.59 M(+2.5%) |
| Jun 2013 | - | -$12.28 M(+3.1%) |
| Mar 2013 | - | -$11.91 M(+2.9%) |
| Dec 2012 | -$11.58 M(+44.8%) | -$11.58 M(+2.4%) |
| Sep 2012 | - | -$11.30 M(+21.2%) |
| Jun 2012 | - | -$9.32 M(+8.5%) |
| Mar 2012 | - | -$8.59 M(+7.4%) |
| Dec 2011 | -$8.00 M(+34.9%) | -$8.00 M(+9.1%) |
| Sep 2011 | - | -$7.33 M(+10.5%) |
| Jun 2011 | - | -$6.63 M(+5.5%) |
| Mar 2011 | - | -$6.28 M(+5.9%) |
| Dec 2010 | -$5.93 M(+17.4%) | -$5.93 M(-2.6%) |
| Sep 2010 | - | -$6.09 M(+6.6%) |
| Jun 2010 | - | -$5.71 M(+5.7%) |
| Mar 2010 | - | -$5.40 M(+6.9%) |
| Dec 2009 | -$5.05 M(+44.3%) | -$5.05 M(+12.9%) |
| Sep 2009 | - | -$4.47 M(+11.3%) |
| Jun 2009 | - | -$4.02 M(+6.4%) |
| Mar 2009 | - | -$3.78 M(+8.0%) |
| Dec 2008 | -$3.50 M(+57.1%) | -$3.50 M(+8.1%) |
| Sep 2008 | - | -$3.24 M(+18.1%) |
| Jun 2008 | - | -$2.74 M(+0.4%) |
| Mar 2008 | - | -$2.73 M(+22.6%) |
| Dec 2007 | -$2.23 M(+341.6%) | -$2.23 M(+15.5%) |
| Sep 2007 | - | -$1.93 M(+91.5%) |
| Jun 2007 | - | -$1.01 M(+21.1%) |
| Mar 2007 | - | -$831.30 K(+64.9%) |
| Dec 2006 | -$504.20 K(+3031.7%) | -$504.20 K(+39.6%) |
| Sep 2006 | - | -$361.10 K(+43.2%) |
| Jun 2006 | - | -$252.20 K(+622.6%) |
| Mar 2006 | - | -$34.90 K |
| Dec 2005 | -$16.10 K | - |
FAQ
- What is Lixte Biotechnology Holdings annual retained earnings?
- What is the all time high annual retained earnings for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings annual retained earnings year-on-year change?
- What is Lixte Biotechnology Holdings quarterly retained earnings?
- What is the all time high quarterly retained earnings for Lixte Biotechnology Holdings?
- What is Lixte Biotechnology Holdings quarterly retained earnings year-on-year change?
What is Lixte Biotechnology Holdings annual retained earnings?
The current annual retained earnings of LIXT is -$48.48 M
What is the all time high annual retained earnings for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high annual retained earnings is -$16.10 K
What is Lixte Biotechnology Holdings annual retained earnings year-on-year change?
Over the past year, LIXT annual retained earnings has changed by -$5.09 M (-11.72%)
What is Lixte Biotechnology Holdings quarterly retained earnings?
The current quarterly retained earnings of LIXT is -$51.45 M
What is the all time high quarterly retained earnings for Lixte Biotechnology Holdings?
Lixte Biotechnology Holdings all-time high quarterly retained earnings is -$34.90 K
What is Lixte Biotechnology Holdings quarterly retained earnings year-on-year change?
Over the past year, LIXT quarterly retained earnings has changed by $0.00 (0.00%)